# AbbVie revenue entity: /record/abbvie.md predicate: revenue page: /record/abbvie/revenue as_of: 2026-11-09 cite: AsOf. "AbbVie quarterly revenue: 17,404,000,000 United States dollar", as of 2026-09-30. Claim clm_DA52AAE1BFB4, https://asof.is/claim/clm_DA52AAE1BFB4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm. As of November 9, 2026, the latest revenue figure on the AsOf record for AbbVie is $17.4 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). AbbVie's latest full-year revenue is $61.16 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 15 claims on AbbVie's revenue, 1 open and 14 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/abbvie/quarterly_revenue.md - [AbbVie](/record/abbvie.md) | quarterly_revenue | 17,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DA52AAE1BFB4](/claim/clm_DA52AAE1BFB4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm ## Latest full-year revenue What the record asserts on 2026-11-09. - [AbbVie](/record/abbvie.md) | revenue | 61,160,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AbbVie](/record/abbvie.md) | revenue | 17,444,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md) | [clm_A43C77B35651](/claim/clm_A43C77B35651.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 18,380,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_10EA1069A66F](/claim/clm_10EA1069A66F.md) | [clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 18,790,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md) | [clm_10EA1069A66F](/claim/clm_10EA1069A66F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | revenue | 19,960,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_778004ECC385](/claim/clm_778004ECC385.md) | [clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | revenue | 22,859,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_B8A18C367510](/claim/clm_B8A18C367510.md) | [clm_778004ECC385](/claim/clm_778004ECC385.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | revenue | 25,638,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_9C790281A637](/claim/clm_9C790281A637.md) | [clm_B8A18C367510](/claim/clm_B8A18C367510.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 28,216,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md) | [clm_9C790281A637](/claim/clm_9C790281A637.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 32,753,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md) | [clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 33,266,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md) | [clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | revenue | 45,804,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md) | [clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | revenue | 56,197,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md) | [clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | revenue | 58,054,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md) | [clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | revenue | 54,318,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md) | [clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | revenue | 56,334,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) | [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | revenue | 61,160,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## What replaced what - $17.44 billion (2011-12-31 to 2012-12-31, [clm_A43C77B35651](/claim/clm_A43C77B35651.md)) was replaced by $18.38 billion from 2012-12-31 ([clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md)) - $18.38 billion (2012-12-31 to 2013-12-31, [clm_7D34A43B5B1E](/claim/clm_7D34A43B5B1E.md)) was replaced by $18.79 billion from 2013-12-31 ([clm_10EA1069A66F](/claim/clm_10EA1069A66F.md)) - $18.79 billion (2013-12-31 to 2014-12-31, [clm_10EA1069A66F](/claim/clm_10EA1069A66F.md)) was replaced by $19.96 billion from 2014-12-31 ([clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md)) - $19.96 billion (2014-12-31 to 2015-12-31, [clm_3A0D33F3133A](/claim/clm_3A0D33F3133A.md)) was replaced by $22.86 billion from 2015-12-31 ([clm_778004ECC385](/claim/clm_778004ECC385.md)) - $22.86 billion (2015-12-31 to 2016-12-31, [clm_778004ECC385](/claim/clm_778004ECC385.md)) was replaced by $25.64 billion from 2016-12-31 ([clm_B8A18C367510](/claim/clm_B8A18C367510.md)) - $25.64 billion (2016-12-31 to 2017-12-31, [clm_B8A18C367510](/claim/clm_B8A18C367510.md)) was replaced by $28.22 billion from 2017-12-31 ([clm_9C790281A637](/claim/clm_9C790281A637.md)) - $28.22 billion (2017-12-31 to 2018-12-31, [clm_9C790281A637](/claim/clm_9C790281A637.md)) was replaced by $32.75 billion from 2018-12-31 ([clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md)) - $32.75 billion (2018-12-31 to 2019-12-31, [clm_67CC49EA52CC](/claim/clm_67CC49EA52CC.md)) was replaced by $33.27 billion from 2019-12-31 ([clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md)) - $33.27 billion (2019-12-31 to 2020-12-31, [clm_EB4D7B27A2A8](/claim/clm_EB4D7B27A2A8.md)) was replaced by $45.8 billion from 2020-12-31 ([clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md)) - $45.8 billion (2020-12-31 to 2021-12-31, [clm_34A920A5AE6F](/claim/clm_34A920A5AE6F.md)) was replaced by $56.2 billion from 2021-12-31 ([clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md)) - $56.2 billion (2021-12-31 to 2022-12-31, [clm_D102FEEF7A89](/claim/clm_D102FEEF7A89.md)) was replaced by $58.05 billion from 2022-12-31 ([clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md)) - $58.05 billion (2022-12-31 to 2023-12-31, [clm_C6FBA5E61236](/claim/clm_C6FBA5E61236.md)) was replaced by $54.32 billion from 2023-12-31 ([clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md)) - $54.32 billion (2023-12-31 to 2024-12-31, [clm_94FBAE0710ED](/claim/clm_94FBAE0710ED.md)) was replaced by $56.33 billion from 2024-12-31 ([clm_46C087CADCC6](/claim/clm_46C087CADCC6.md)) - $56.33 billion (2024-12-31 to 2025-12-31, [clm_46C087CADCC6](/claim/clm_46C087CADCC6.md)) was replaced by $61.16 billion from 2025-12-31 ([clm_4A7BE8ED0078](/claim/clm_4A7BE8ED0078.md)) ## Questions this record answers ### What is AbbVie's current revenue? The latest figure on the record is $17.4 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $61.16 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was AbbVie's revenue for the quarter ended September 30, 2026? $17.4 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did AbbVie's revenue last change? The latest value on the record is $61.16 billion, dated December 31, 2025; before it the record holds $56.33 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AbbVie's revenue before $61.16 billion? $56.33 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/abbvie/revenue (markdown: /record/abbvie/revenue.md) - Entity twin: /record/abbvie.md ยท timeline: /timelines/abbvie.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.